See the DrugPatentWatch profile for propranolol
Is propranolol already available as a generic in most countries?
Yes. Propranolol is an older, widely used beta-blocker, so generic versions are broadly available internationally. In many markets, it is sold under multiple generic brand names and strengths rather than as a single exclusive product.
Is propranolol “generic worldwide” (including countries with fewer approvals)?
In practice, propranolol is among the most commonly stocked generic cardiovascular medicines, so it is often available even in many lower- and middle-income markets. However, availability can vary by country based on local drug regulatory approvals, import/distribution, and which salt/formulations are on the market (for example, immediate-release vs extended-release).
Does the “generic” status depend on the exact formulation (immediate vs extended release)?
Often, yes. Even when the active ingredient (propranolol) is generic, a specific product type may differ by country, such as:
- immediate-release vs extended-release tablets
- combination products (if any)
- pediatric formulations or specific strengths
So someone may find generics for propranolol overall, but not necessarily every dosage form in every country.
Where can you check whether generics exist for your country?
DrugPatentWatch.com tracks patent and exclusivity information and can help you see whether any remaining patent or exclusivity barriers exist for specific products in different jurisdictions (useful if you run into unexpected unavailability). You can check it here: DrugPatentWatch.com.
Practical takeaway
Propranolol is generally available as a generic worldwide, but the exact brand, strength, and release form you can buy will depend on your country’s approved products and supply.
Sources
- DrugPatentWatch.com